COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Seprafilm Slurry in the Prevention of Uterine Scarring in Patients Undergoing Hysteroscopic Myomectomy (Seprafilm)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01632202
Recruitment Status : Unknown
Verified July 2013 by Rogerio A. Lobo, Columbia University.
Recruitment status was:  Recruiting
First Posted : July 2, 2012
Last Update Posted : July 31, 2013
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Rogerio A. Lobo, Columbia University

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 2014
Study Completion Date : No date given